glp 1 agonist muscle loss matters: the effects of medically induced weight on skeletal muscle What Are GLP-1 Agonists For

GLP-1 RAs are recommended in the treatment guidelines by the American Diabetes Association as well as the American Association of Clinical Endocrinology (AACE) Consensus Statement & European Society of Cardiology for type 2 diabetes mellitus patients with co-morbidities, like established atherosclerotic cardiovascular disease and obesity

2.3 Neuroinflammation and cognitive dysfunction in diabetes Diabetes, as a chronic metabolic disorder, induces a chronic inflammatory state that damages the central nervous system

Abstract Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

(Lausanne) 8, 630962

C., Zdravkovic, M., Le Thi, T

A., Kemmeries, G., Holst, J